Adlai Nortye (ANL) Current Assets (2022 - 2025)
Adlai Nortye's (ANL) quarterly Current Assets came in at $26.9 million in Q4 2025, down 58.02% year-on-year from $64.1 million in Q4 2024, and down 58.93% on a QoQ basis from $65.5 million in Q2 2025.
Adlai Nortye (ANL) Current Assets (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Current Assets data on file, last reported at $26.9 million in Q4 2025.
- On a quarterly basis, Current Assets fell 58.02% year-over-year to $26.9 million in Q4 2025; TTM through Dec 2025 was $26.9 million, a 58.02% decrease from a year earlier, with the FY2025 full-year figure at $26.9 million, down 58.02% from the prior year.
- Current Assets for Q4 2025 stood at $26.9 million, down from $65.5 million in the prior quarter.
- Over the last five years, Current Assets for ANL reached as high as $101.2 million in Q4 2023 and fell as low as $26.9 million in Q4 2025.
- Historically, Current Assets has averaged $70.7 million across 4 years, with a median of $65.9 million in 2022.
- Across the five-year window, Current Assets surged 52.63% in 2023 and plunged 58.02% in 2025, its largest moves.
- Year by year, Current Assets stood at $66.3 million in 2022, then surged by 52.63% to $101.2 million in 2023, then slumped by 36.69% to $64.1 million in 2024, then plunged by 58.02% to $26.9 million in 2025.
- Per Business Quant data, the three most recent Current Assets figures were $26.9 million in Q4 2025, $65.5 million in Q2 2025, and $64.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.97 Bn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 26.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.89 Mn |
| Jun 30, 2025 | 65.48 Mn |
| Dec 31, 2024 | 64.06 Mn |
| Jun 30, 2024 | 100.28 Mn |
| Dec 31, 2023 | 101.20 Mn |
| Dec 31, 2022 | 66.30 Mn |